Catheter-directed thrombolytic therapy for acute superior mesenteric vein thrombus: comparison between via venous route and via arterial route
10.3969/j.issn.1008-794X.2015.12.018
- VernacularTitle:急性肠系膜上静脉血栓经静脉和动脉途径溶栓比较
- Author:
Wei LI
;
Zongen GAO
;
Shouguang SUI
;
Ying XIAO
;
Hongfeng SHI
;
Xiaofei ZHANG
;
Jing SHANG
- Publication Type:Journal Article
- Keywords:
superior mesenteric vein thrombosis;
interventional therapy;
thrombolysis
- From:
Journal of Interventional Radiology
2015;24(12):1098-1101
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical effects of catheter-directed thrombolytic therapy for acute superior mesenteric vein thrombus (SMVT) between via superior mesenteric vein (SMV) route and via superior mesenteric artery (SMA) route. Methods The clinical data of 32 patients with acute SMVT, who were treated with catheter-directed thrombolytic therapy at the Central Hospital of Shengli Oil Field, were retrospectively analyzed. Among the 32 patients, percutaneous transhepatic catheter-directed thrombolytic therapy via SMV route was performed in 23 (SMV group), and percutaneous transhepatic catheter-directed thrombolytic therapy via SMA route was carried out in 9 (SMA group). Results After the treatment, the clinical symptoms were significantly improved in 28 patients, including 22 of SMV group (95.7%) and 6 of SMA group (66.7%). CT angiography showed that the blood flow became almost complete patency in 17 patients of SMV group (73.9%) and in only 3 patients of SMA group (33.3%). Both the thrombolysis procedure time and X-ray exposure time of SMV group were obviously longer than those of SMA group. Conclusion Both via SMV and via SMA catheter-directed thrombolytic therapies are effective treatment for acute SMV thrombosis. The former is more effective, while the manipulation of the latter is technically simpler.
